M. Seke

4.5k citations
6 papers · 756 · 1 hit paper · h-index 6

Impact in

  • Radiation top 5%
    • Advanced Radiotherapy Techniques
    • Prostate Cancer Diagnosis and Treatment
    • Prostate Cancer Treatment and Research
    • Radiation Therapy and Dosimetry
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Prostate Cancer Diagnosis and Treatment 5
    • Prostate Cancer Treatment and Research 1
    • Radiation Therapy and Dosimetry 1
    • Lung Cancer Diagnosis and Treatment 1
    • Hepatocellular Carcinoma Treatment and Prognosis 2

M. Seke

6 papers receiving 753 citations

M. Seke's Hit Papers

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial 2019 · 574 citations
5740+2+4Years since publication100200300400500

Peers

M. Seke
Comparison fields: 5 of 41
  • Radiation 216
  • Pulmonary and Respiratory Medicine 524
  • Radiology, Nuclear Medicine and Imaging 82
  • Otorhinolaryngology 7
  • Oncology 40
Replace Kirsten Björnlinger with:
Kirsten Björnlinger Sweden
Eric E. K. Yeoh Australia
Magnus Lagerlund Sweden
C Marion United States
Ruth Peter United States
Theresa Wolfe United States
Michela Marcenaro Italy
Juan Martin Magsanoc United States
Alberto Bossi Italy
Masayuki Araya Japan
M. Seke relative to Kirsten Björnlinger Sweden Kirsten Björnlinger's profile →
Citations per field
00.5×1.5×2.2×
Kirsten Björnlinger · 1×
Citations per year

Countries citing papers authored by M. Seke

Since Specialization
Citations

This map shows the geographic impact of M. Seke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Seke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Seke more than expected).

Fields of papers citing papers by M. Seke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Seke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Seke. The network helps show where M. Seke may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Seke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Seke Line = papers co-authored together M. Seke links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Hit paper breakdown →
2019574
2 202197
3 201627
4 200823
5 201221
6 201814

About M. Seke

M. Seke is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Infectious Diseases, Organic Chemistry and Surgery, having authored 6 papers that have together received 756 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Prostate Cancer Treatment and Research (1 paper), Radiation Therapy and Dosimetry (1 paper) and Lung Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Radiation (216 citations), Pulmonary and Respiratory Medicine (524 citations), Radiology, Nuclear Medicine and Imaging (82 citations), Otorhinolaryngology (7 citations) and Oncology (40 citations). M. Seke has collaborated with scholars based in Sweden, Denmark and Finland. Frequent co-authors include Lars Franzén, Camilla Thellenberg‐Karlsson, Claes Ginman, Elisabeth Kjellén, Bengt Johansson, Magnus Lagerlund, L. Beckman, Jon Kindblom, Anders Widmark and Morten Høyer. Their work appears in journals such as Radiotherapy and Oncology, The Lancet Oncology, Lung Cancer, Prostate Cancer and Prostatic Diseases and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact